Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020

Robert Hsu, Kai‐Ya Tsai, David J. Benjamin, Krithika Chennapan, Katherine Y. Wojcik, Alice W. Lee, Jacob Thomas, Jorge J. Nieva, Lihua LiuCancers 2024 · DOI

TL;DR

Hispanics in California show a higher incidence of advanced thyroid cancer and a greater risk of mortality compared to other racial/ethnic groups, even after accounting for demographic and tumor characteristics. This highlights persistent disparities that warrant further investigation into genetic and socioeconomic factors.

What Problem Does This Paper Address?

Thyroid cancer incidence has been rising globally, and while previous studies have indicated lower incidence rates among Hispanic populations compared to non-Hispanic Whites and Asian Pacific Islanders, they also suggested a higher prevalence of advanced disease features (larger tumors, lymph node involvement) and potentially worse outcomes. However, findings on survival have been mixed, and the increasing Hispanic population in California, coupled with potential influences of overdiagnosis and healthcare access, necessitates a contemporary examination of these disparities. This paper aims to characterize Hispanic thyroid cancer cases in California from 2010-2020, focusing on demographic features, tumor characteristics, and mortality risk, to understand if these trends persist and to identify potential contributing factors.

Methods

The researchers utilized data from the California Cancer Registry (CCR) for thyroid cancer cases diagnosed between 2010 and 2020. They analyzed demographic characteristics (sex, age, race/ethnicity, socioeconomic status), tumor behavior (histology, TNM stage, tumor size, lymph node involvement), and Charlson comorbidity scores. Age-adjusted incidence rates (AAIR) and age-adjusted mortality rates (AAMR) were calculated. A Cox proportional hazards regression analysis was performed to evaluate the mortality risk from all causes of death, adjusting for various demographic and tumor covariates. Statistical significance was set at p < 0.1.

Datasets

The primary dataset used was the California Cancer Registry (CCR) Research File, accessed in July 2023, containing thyroid cancer cases diagnosed from 2010 to 2020 among California residents. Statewide mortality data with causes of death information was also utilized, sourced from the California Department of Public Health's Center for Health Statistics Death Master Files (1970-2020).

Key Insights and Ideas

  • Persistent Sex Disparity: The female-to-male incidence rate ratio (IRR) for thyroid cancer is significantly higher in the Hispanic population, suggesting unique biological or behavioral factors at play.
  • Advanced Disease Presentation: Despite potentially lower overall incidence, Hispanics are more likely to be diagnosed with advanced stage thyroid cancer, characterized by larger tumor sizes (T3/T4) and lymph node involvement (N1).
  • Increased Mortality Risk: Hispanic ethnicity remains a significant independent predictor of mortality from thyroid cancer, even after controlling for a comprehensive set of demographic and tumor-related factors.
  • Socioeconomic Influence: Lower socioeconomic status emerged as a significant risk factor for mortality, highlighting the interplay between economic factors and health outcomes in this population.

Key Results

  • Prevalence: Hispanics constituted 29.75% of the 56,638 thyroid cancer cases identified in California from 2010 to 2020.
  • Sex Disparity: Hispanics exhibited the highest female-to-male incidence rate ratio (IRR) of 3.54.
  • Disease Characteristics: Hispanics showed the highest prevalence of T3/T4 tumor size (28.71%) and N1 nodal status (32.69%).
  • Mortality: Hispanics had the highest age-adjusted mortality rate (AAMR) of 0.79 per 100,000 people.
  • Mortality Risk: After adjusting for covariates, Hispanic ethnicity remained a significant predictor of mortality, with a hazard ratio (HR) of 1.21 (95% CI 1.18–1.24, p < 0.0001).

Limitations and Future Work

The authors acknowledge that their analysis is limited to Hispanics in California, which may not be generalizable to Hispanic populations elsewhere due to regional differences in ethnic composition and socioeconomic factors. They also highlight the lack of genetic testing data, which limits the ability to explore the role of specific genetic mutations (like BRAF V600E and TERT) in driving disparities.

Future work should focus on:

  • Disaggregating data within Hispanic subgroups to understand variations based on origin (e.g., Mexican vs. Caribbean descent).
  • Conducting comparative molecular testing for key mutations (BRAF, RET) among different Hispanic subgroups and other racial/ethnic groups.
  • Investigating the differences between U.S.-born and foreign-born Hispanic individuals.
  • Exploring the impact of undocumented immigrant status on data availability and risk assessment.
  • Further research into the role of genetic alterations, socioeconomic factors, and access to care to bridge the observed disparities in thyroid cancer outcomes.

Summary updated

Abstract

Hispanics had the greatest female-to-male IRR ratio, a greater prevalence of advanced disease features at diagnosis, along with the highest AAMR and increased mortality risk despite adjustments for demographic and tumor covariates. Further investigation into other risk factors is needed.
BibTeX
@inproceedings{hsu2024characterization,
  author = {Robert Hsu and Kai‐Ya Tsai and David J. Benjamin and Krithika Chennapan and Katherine Y. Wojcik and Alice W. Lee and Jacob Thomas and Jorge J. Nieva and Lihua Liu},
  title = {{Characterization of Thyroid Cancer among Hispanics in California, USA, from 2010 to 2020}},
  booktitle = {Cancers},
  year = {2024},
  doi = {10.3390/cancers16061101},
}
Figure